Sort   by:  
 Page size 
ProteomicsSIK2-dependent Phosphoproteome and Interactome upon Salmonella infection
HeLa cells transfected with non-targeting control- and anti-SIK2 siRNA were left uninfected or infected with Salmonella and lysed 30 min pi. Following tryptic-digest peptides were labeled using TMT-pro 16-plex and phosphopeptides enriched. The endogenously tagged SIK2-HA IP workflow. Hela wild type ...
ORGANISM(S): Homo sapiens (Human) 
2021-05-06 | PXD021859 | Pride
Homo sapiens (human) 
ProteomicsHuman hypertrophic cardiomyopathy cardiac tissue phosphoproteomics
This study used TMT-pro method to look for phosphoproteomic differences in heart tissue of patients with hypertrophic cardiomyopathy and controls
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-04-28 | MSV000091822 | MassIVE
ProteomicsIFN gamma induced changes in MSC secretome
IFN gamma induced changes in MSC secretome. Secretome was measured by nanoLCMSMS ising a velos pro and the intracellular proteome via a QExactive via TMT labeling of both.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Rattus (ncbitaxon:10114) 
MSV000082984 | MassIVE
UnknownEffect of rottlerin on astrocyte phenotype polarization after trimethyltin insult in the dentate gyrus of mice.
Not available
S-EPMC9188234 | biostudies-literature
UnknownTrimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model.
Not available
S-EPMC9054325 | biostudies-literature
ProteomicsPolyserine-mediated targeting of FAF2/UBXD8 ameliorates tau aggregation
Tau aggregation is a hallmark of several neurodegenerative disorders and gain of toxic functions of misfolded tau species are linked to pathobiology. Herein, we identified proteins that limit tau aggregation when targeted to tau aggregates by polyserine domains. Polyserine targeting was most effecti...
ORGANISM(S): Mus musculus (Mouse) 
2025-09-03 | PXD066746 | Pride
Tmt-pro 
ProteomicsProteome expression changes upon Halofuginone treatment
NHCF-V primary cardiac fibroblasts where treated for 24 hours with either 1) 100nM Halofuginone (TMT labels 126 and 129L) 2) 300nM Halofuginone (TMT labels 127L and 129H) 3) 300 nM Halofuginone + 4 mM L-Pro (TMT labels 127H and 130L) 4) DMSO (TMT labels 128H and 131)
ORGANISM(S): Homo sapiens (Human) 
2017-05-16 | PXD005679 | Pride
Primary cardiac fibroblasts Human Halofuginone 
UnknownDevelopment of an Adaptive, Economical, and Easy-to-Use SP3-TMT Automated Sample Preparation Workflow for Quantitative Proteomics.
Not available
S-EPMC11888279 | biostudies-literature
UnknownDevelopment of an Adaptive, Economical, and Easy-to-Use SP3-TMT Automated Sample Preparation Workflow for Quantitative Proteomics.
Not available
S-EPMC12150330 | biostudies-literature
UnknownCase Report: Transient myocardial thickening in a cat secondary to acute cholangiohepatitis.
Not available
S-EPMC12855061 | biostudies-literature
Sort   by:  
 Page size